UPDATED Apr 29, 2024
Companies with a Value score of at least 3, ordered by Value score
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
LAB B | Mex$16.67 | 10.5% | 8.2% | Mex$15.2b | Mex$20.60 | PE14.8x | E26.7% | 4.7% | ||
EXAS * | US$1,141.00 | 0% | n/a | US$10.8b | US$1,734.71 | PS4.3x | E61.9% | n/a | ||
INDV N | UK£314.49 | -51.3% | -51.3% | UK£1.9b | UK£478.88 | PE14.1x | E14.4% | 0% | ||
GILD * | US$1,121.00 | -0.8% | -22.7% | US$82.2b | US$1,429.73 | PE169.5x | E35.8% | 4.7% | ||
BIIB * | US$3,700.00 | 12.5% | -33.4% | US$31.4b | US$4,909.87 | PE26.9x | E17.8% | n/a | ||
1093 N | HK$15.69 | 0% | -27.0% | HK$69.4b | HK$25.29 | PE10.4x | E1.4% | 4.7% | ||
RARE * | US$751.98 | 0% | 5.3% | US$4.2b | US$1,337.13 | PS9.6x | E48.2% | n/a | ||
REGN * | US$15,516.00 | 1.3% | 6.4% | US$95.3b | US$18,047.33 | PE24.4x | E11.2% | n/a | ||
NVAX * | US$69.07 | -0.07% | -49.9% | US$572.4m | US$247.94 | PE-1.1x | E78.4% | n/a | ||
GSK1 N | UK£357.35 | 0% | n/a | UK£68.2b | UK£429.20 | PE13.8x | E9.3% | 3.5% | ||
INCY * | US$986.00 | 0% | n/a | US$11.8b | US$1,410.72 | PE19.7x | E18.8% | n/a | ||
OGN * | US$299.00 | 0% | -29.5% | US$4.9b | US$344.09 | PE4.8x | E3.8% | 5.9% | ||
JNJ * | US$2,485.48 | -2.3% | -16.7% | US$353.8b | US$2,938.79 | PE18.5x | E5.1% | 3.4% | ||
PRGO N | US$686.00 | 0% | -3.8% | US$4.9b | US$902.68 | PS1.1x | S3.9% | 3.0% | ||
HALO * | US$680.00 | 0% | 0.04% | US$5.2b | US$873.74 | PE20.5x | E24.1% | n/a | ||
BGNE N | US$2,858.16 | 0% | n/a | US$14.0b | US$5,727.85 | PS5.7x | E56.2% | n/a | ||
VTRS * | US$192.00 | 0.1% | 15.7% | US$14.0b | US$202.03 | PE255.8x | E16.0% | 4.1% | ||
ELAN * | US$479.28 | 0% | 0% | US$4.6b | US$675.27 | PS1x | E35.9% | n/a | ||
IPN N | €1,936.56 | 0% | n/a | €9.3b | €2,146.10 | PE15.1x | E6.3% | 1.1% | ||
TEVA N | US$242.00 | 9.9% | 61.3% | US$16.0b | US$270.08 | PS1x | E32.1% | 0% | ||
MRNA * | US$1,903.00 | 3.3% | -19.1% | US$42.7b | US$2,289.66 | PS6.2x | E56.0% | n/a | ||
IFRX N | US$27.00 | 0% | n/a | US$81.8m | US$155.03 | PS1211.8x | E26.5% | n/a | ||
RPRX N | US$482.00 | 0% | n/a | US$16.9b | US$778.19 | PE11.2x | E6.0% | 3.0% | ||
ACAD * | US$509.00 | 0% | 60.5% | US$3.8b | US$679.54 | PS7x | E61.6% | n/a |